Medtronic Posts Q4 Beat Driven by Cardiovascular Segment Growth

Medtronic reported a strong fourth-quarter beat, with its cardiovascular and diabetes segments continuing their double-digit growth streaks. The company's performance was notably boosted by its cardiovascular division.